心臓弁の世界市場:機械式心臓弁、組織心臓弁、経カテーテル心臓弁

◆英語タイトル:Global Heart Valves Market 2016-2020
◆商品コード:IRTNTR9025
◆発行会社(調査会社):Technavio
◆発行日:2016年6月8日
◆ページ数:67
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、心臓弁の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、心臓弁の世界市場規模及び予測、種類別分析、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About the Heart Valves Market
Heart valves are prosthetic cardiovascular medical devices used to replace a defective heart valve. They can be biological, tissue or mechanical. Manufacturers develop mechanical heart valves from synthetic materials such as pyrolytic carbon, titanium alloy, and cobalt-based alloys and tissue heart valves from bovine, porcine, and human tissues. They also develop transcatheter heart valves with a combination of tissue and synthetic materials. Devices developed using human tissues are known as allografts or homografts. Medical personnel implant transcatheter heart valves through the transfemoral approach (via the femoral artery) and transapical approach (via a small chest incision). Medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

Technavio’s analysts forecast the global heart valves market to grow at a CAGR of 14.28% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global heart valves market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of prosthetic heart valve products such as:
• Mechanical heart valves: Caged ball, tilting disc, and bileaflet valves
• Tissue heart valves: Stented and stentless tissue valves
• Transcatheter heart valves: Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) devices

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Edwards Lifesciences
• LivaNova
• Medtronic
• St. Jude Medical

[Other prominent vendors]
• Abbott Laboratories
• Braile Biomedica
• Cardious
• Colibri Heart Valve
• corlife OHG
• JenaValve Technology
• Lepu Medical Technology (Beijing)
• Meril Life Sciences
• Neovasc
• ON-X Life Technologies
• Pulmonx
• Roskardioinvest
• SYMETIS

[Market driver]
• Implementation of minimally invasive procedures
• For a full, detailed list, view our report

[Market challenge]
• v
• For a full, detailed list, view our report

[Market trend]
• Use of stentless tissue valves
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Cost analysis
• Cost analysis of valve replacement procedures

PART 07: Market segmentation by product
• Global mechanical heart valves market
• Global tissue heart valves market
• Global transcatheter heart valves market

PART 08: Geographical segmentation
• Heart valves market in Americas
• Heart valves market in EMEA
• Heart valves market in APAC

PART 09: Market drivers
• Incidence of heart valve diseases
• Implementation of minimally invasive procedures
• Use of transcatheter valve replacement technology
• Rise in older population

PART 10: Impact of drivers

PART 11: Market challenges
• Risk of potential complications
• Lack of skilled personnel
• Expensive heart valve replacement procedures
• Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Focus on US
• Increase in M&A
• Use of stentless tissue valves
• Development of novel heart valves

PART 14: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Key vendors
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

PART 16: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global heart valves market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
Exhibit 05: Global heart valves market segmentation by product
Exhibit 06: Global heart valves market segmentation by product 2015
Exhibit 07: Global heart valves market segmentation by product 2020
Exhibit 08: Global heart valves market segmentation by product 2015-2020
Exhibit 09: Global mechanical heart valves market segmentation by type
Exhibit 10: Characteristics of mechanical valves
Exhibit 11: Global mechanical heart valves market 2015-2020 ($ millions)
Exhibit 12: Global tissue heart valves market segmentation by type 2015
Exhibit 13: Global tissue heart valves market 2015-2020 ($ billion)
Exhibit 14: Global transcatheter heart valves market by type 2015
Exhibit 15: Global transcatheter heart valves market 2015-2020 ($ billions)
Exhibit 16: Global heart valves market segmentation by geography 2015
Exhibit 17: Global heart valves market segmentation by geography 2020
Exhibit 18: Global heart valves market segmentation by geography 2015-2020
Exhibit 19: Heart valves market in Americas 2015-2020 ($ billions)
Exhibit 20: Heart valves market in EMEA 2015-2020 ($ billions)
Exhibit 21: Heart valves market in APAC 2015-2020 ($ billions)
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Major acquisitions 2015
Exhibit 25: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 26: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 27: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 28: Edwards Lifesciences: Business segmentation by revenue 2015
Exhibit 29: Edwards Lifesciences: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 30: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment 2013-2015 ($ millions)
Exhibit 31: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in US 2013-2015 ($ millions)
Exhibit 32: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in ROW 2013-2015 ($ millions)
Exhibit 33: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment 2013-2015 ($ millions)
Exhibit 34: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in US 2013-2015 ($ millions)
Exhibit 35: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in ROW 2013-2015 ($ millions)
Exhibit 36: Edwards Lifesciences: Key takeaways
Exhibit 37: LivaNova: Revenue of cardiac surgery segment by geography 2015
Exhibit 38: LivoNova: Key takeaways
Exhibit 39: Medtronic: Product portfolio
Exhibit 40: Medtronic: Product segmentation by revenue 2015
Exhibit 41: Medtronic: Key takeaways
Exhibit 42: St. Jude Medical: Product portfolio
Exhibit 43: St. Jude Medical: Revenue and YoY growth of structural heart segment 2013-2015 ($ millions)
Exhibit 44: St. Jude Medical: Key takeaways
Exhibit 45: Other prominent vendors



【掲載企業】

Edwards Lifesciences, LivaNova, Medtronic, St. Jude Medical, Abbott Laboratories, Braile Biomedica, Cardious, Colibri Heart Valve, corlife OHG, JenaValve Technology, Lepu Medical Technology (Beijing), Meril Life Sciences, Neovasc, ON-X Life Technologies, Pulmonx, Roskardioinvest, SYMETIS.

【レポートのキーワード】

心臓弁、機械式心臓弁、組織心臓弁、経カテーテル心臓弁

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[心臓弁の世界市場:機械式心臓弁、組織心臓弁、経カテーテル心臓弁]販売に関する免責事項
★調査レポート[心臓弁の世界市場:機械式心臓弁、組織心臓弁、経カテーテル心臓弁]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆